Peter Quehenberger

10.4k total citations · 1 hit paper
204 papers, 7.8k citations indexed

About

Peter Quehenberger is a scholar working on Hematology, Internal Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Peter Quehenberger has authored 204 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Hematology, 62 papers in Internal Medicine and 45 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Peter Quehenberger's work include Blood Coagulation and Thrombosis Mechanisms (69 papers), Venous Thromboembolism Diagnosis and Management (62 papers) and Platelet Disorders and Treatments (36 papers). Peter Quehenberger is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (69 papers), Venous Thromboembolism Diagnosis and Management (62 papers) and Platelet Disorders and Treatments (36 papers). Peter Quehenberger collaborates with scholars based in Austria, United States and Germany. Peter Quehenberger's co-authors include Ingrid Pabinger, Cihan Ay, Bernd Jilma, Christoph Zielinski, Daniela Dunkler, Paul A. Kyrle, Rainer Vormittag, Christine Mannhalter, Wolfgang Speiser and Ralph Simanek and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Oncology.

In The Last Decade

Peter Quehenberger

195 papers receiving 7.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prediction of venous thromboembolism in cancer patients

2010 570 citations Cihan Ay, Peter Quehenberger et al. Blood profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Peter Quehenberger	3.0k	2.8k	2.1k	1.1k	833	204	7.8k
Armando D’Angelo	3.0k 1.0×	2.6k 0.9×	2.4k 1.1×	1.9k 1.6×	1.3k 1.5×	192	9.1k
Thomas Lecompte	3.2k 1.1×	1.8k 0.6×	1.7k 0.8×	1.1k 0.9×	532 0.6×	239	6.6k
Domenico Prisco	2.0k 0.7×	2.3k 0.8×	3.1k 1.5×	1.7k 1.5×	832 1.0×	376	9.5k
Matteo Nicola Dario Di Minno	1.9k 0.7×	1.4k 0.5×	1.7k 0.8×	1.4k 1.2×	1.3k 1.6×	274	8.2k
Paolo Gresele	3.8k 1.3×	1.0k 0.4×	2.5k 1.2×	1.7k 1.4×	753 0.9×	311	10.1k
J W ten Cate	2.2k 0.8×	1.9k 0.7×	1.4k 0.7×	1.5k 1.3×	988 1.2×	168	6.3k
Per Morten Sandset	3.7k 1.3×	5.0k 1.8×	3.5k 1.7×	2.8k 2.4×	1.0k 1.2×	312	10.6k
Jan W. ten Cate	3.1k 1.0×	4.2k 1.5×	2.5k 1.2×	2.1k 1.8×	931 1.1×	110	7.9k
Philippe de Moerloose	3.2k 1.1×	1.7k 0.6×	1.2k 0.6×	1.0k 0.9×	691 0.8×	220	8.2k
Maureane Hoffman	5.9k 2.0×	1.3k 0.5×	1.5k 0.7×	1.8k 1.5×	1.1k 1.3×	203	11.6k

Countries citing papers authored by Peter Quehenberger

Since Specialization

Citations

This map shows the geographic impact of Peter Quehenberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Quehenberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Quehenberger more than expected).

Fields of papers citing papers by Peter Quehenberger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Quehenberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Quehenberger. The network helps show where Peter Quehenberger may publish in the future.

Co-authorship network of co-authors of Peter Quehenberger

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Quehenberger. A scholar is included among the top collaborators of Peter Quehenberger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Quehenberger. Peter Quehenberger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ay, Cihan, et al.. (2025). Estimating the Factor VIII‐Equivalent Activity of Emicizumab Using Global Assays of Haemostasis. Haemophilia. 31(5). 1092–1102.

Nopp, Stephan, Florian Moik, Angelika M. Starzer, et al.. (2025). The Vienna CATScore for predicting cancer-associated venous thromboembolism: an external validation across multiple time points. ESMO Open. 10(2). 104130–104130. 2 indexed citations

Scheiner, Bernhard, Alberto Zanetto, Lorenz Balcar, et al.. (2024). Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease. Alimentary Pharmacology & Therapeutics. 59(11). 1376–1386. 3 indexed citations

Gratz, Johannes, et al.. (2024). Detection of enoxaparin and argatroban by use of the novel viscoelastic coagulometer ClotPro. Scientific Reports. 14(1). 29520–29520.

Balcar, Lorenz, Benedikt Simbrunner, Rafael Paternostro, et al.. (2023). Platelet adhesion assessed by PFA-100 is not linked to progression of ACLD. JHEP Reports. 6(1). 100934–100934. 2 indexed citations

Fillitz, Michael, et al.. (2023). Vitamin D deficiency in adult patients with primary immune thrombocytopenia (ITP) from the Vienna ITP Biobank. Hämostaseologie. 43(S 01). S72–S73.

Grilz, Ella, Oliver Königsbrügge, Cornelia Gabler, et al.. (2023). Bleeding phenotype in nonsevere hemophilia by International Society on Thrombosis and Haemostasis bleeding assessment tool, bleeding frequency, and the joint status. Research and Practice in Thrombosis and Haemostasis. 7(2). 100047–100047. 6 indexed citations

Scheiner, Bernhard, Lorenz Balcar, Rafael Paternostro, et al.. (2022). Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLD. Journal of Hepatology. 76(5). 1090–1099. 24 indexed citations

Ay, Cihan, Ingrid Pabinger, Georg Gelbenegger, et al.. (2022). The VWF binding aptamer rondoraptivon pegol increases platelet counts and VWF/FVIII in type 2B von Willebrand disease. Blood Advances. 6(18). 5467–5476. 20 indexed citations

10.

Königsbrügge, Oliver, Stephan Nopp, Florian Moik, et al.. (2022). Antithrombin Activity and Association with Risk of Thrombosis and Mortality in Patients with Cancer. International Journal of Molecular Sciences. 23(24). 15770–15770. 2 indexed citations

11.

Ay, Cihan, Christian Schoergenhofer, Georg Gelbenegger, et al.. (2022). The von Willebrand factor–binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A. Blood. 141(10). 1147–1158. 18 indexed citations

12.

Puhr, Hannah Christina, Aysegül Ilhan‐Mutlu, Matthias Preusser, et al.. (2022). Absorption of Direct Oral Anticoagulants in Cancer Patients after Gastrectomy. Pharmaceutics. 14(3). 662–662. 5 indexed citations

13.

Mangold, Andreas, Anna S. Ondracek, Thomas M. Hofbauer, et al.. (2021). Culprit site extracellular DNA and microvascular obstruction in ST-elevation myocardial infarction. Cardiovascular Research. 118(8). 2006–2017. 27 indexed citations

14.

Semmler, Georg, Katharina Pomej, David Bauer, et al.. (2021). Safety of direct oral anticoagulants in patients with advanced liver disease. Liver International. 41(9). 2159–2170. 32 indexed citations

15.

Hartl, Lukas, Mathias Jachs, Benedikt Simbrunner, et al.. (2021). Cirrhosis-Associated RAS-Inflammation-Coagulation Axis Anomalies: Parallels to Severe COVID-19. Journal of Personalized Medicine. 11(12). 1264–1264. 8 indexed citations

16.

Perkmann, Thomas, Nicole Perkmann‐Nagele, Marie‐Kathrin Breyer, et al.. (2020). Side-by-Side Comparison of Three Fully Automated SARS-CoV-2 Antibody Assays with a Focus on Specificity. Clinical Chemistry. 66(11). 1405–1413. 80 indexed citations

17.

Königsbrügge, Oliver, Ella Grilz, Stefanie Hofer, et al.. (2020). Influence of blood group, von Willebrand factor levels, and age on factor VIII levels in non‐severe haemophilia A. Journal of Thrombosis and Haemostasis. 18(5). 1081–1086. 15 indexed citations

18.

Scheiner, Bernhard, Patrick G. Northup, Georg Semmler, et al.. (2020). The impact of ABO blood type on the prevalence of portal vein thrombosis in patients with advanced chronic liver disease. Liver International. 40(6). 1415–1426. 23 indexed citations

19.

Krebs, Michael, Bernhard M. Meyer, Peter Quehenberger, et al.. (2002). Massive postoperative intramuscular bleeding in acquired von Willebrand's disease. Annals of Hematology. 81(7). 394–396. 5 indexed citations

20.

Quehenberger, Peter, et al.. (1990). Occurrence of complement-fixing antibodies against Chlamydia psittaci and Toxoplasma gondii in pigs in the individual counties of Austria.. Wiener Tierarztliche Monatsschrift. 77(9). 285–290. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact